MedPath
TGA Approval

Lozanoc 50 mg capsules (216603)

216603

Lozanoc 50 mg capsules

Mayne Pharma International Pty Ltd

October 25, 2013

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

itraconazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lozanoc 50 mg capsules (216603) - TGA 批准文号 | MedPath